Core Viewpoint - Streamline Health Solutions, Inc. reported a decline in revenue for the fourth quarter and fiscal year 2024, primarily due to SaaS non-renewals and lower revenue from legacy contracts, while emphasizing a focus on innovation and client engagement to drive future growth [1][3][4]. Financial Performance - Total revenue for Q4 2024 was 4.7million,downfrom5.4 million in Q4 2023. For the fiscal year, revenue totaled 17.9millioncomparedto22.6 million in the previous year [3]. - SaaS revenue for Q4 2024 was 3.1million,representing663.4 million (64%) in Q4 2023. For the fiscal year, SaaS revenue was 11.8million(6614.1 million (62%) in fiscal 2023 [4]. - The net loss for Q4 2024 was (2.1million),comparedtoanetlossof(1.4 million) in Q4 2023. The total net loss for fiscal 2024 was (10.2million),animprovementfrom(18.7 million) in fiscal 2023 [5]. Cash Position and Liabilities - Cash and cash equivalents as of January 31, 2025, were 2.2million,downfrom3.2 million a year earlier. The company had an outstanding balance of 1.0milliononitsrevolvingcreditfacility[6].−Totalliabilitiesincreasedto23.3 million as of January 31, 2025, compared to 22.9millioninthepreviousyear[23].AdjustedEBITDA−AdjustedEBITDAforQ42024was35,000, down from 0.4millioninQ42023.Forthefiscalyear,adjustedEBITDAwasalossof(1.3 million), slightly improved from a loss of (1.4million)infiscal2023[7][28].BookedSaaSAnnualContractValue(ACV)−AsofJanuary31,2025,thetotalBookedSaaSACVwas14.0 million, down from 15.0millionayearearlier,largelyduetoclientnon−renewals,butoffsetby3.5 million in new bookings during fiscal 2025 [8][9]. Future Outlook - The company expects to achieve an adjusted EBITDA positive run rate during the first half of fiscal 2025, although specific guidance on timing for bookings has not been provided due to unpredictability [11].